Analysts lift fair value for Meiji stock to JPY 4,655

Published on 10/07/2026 at 05:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue reached JPY 289.4 billion in fiscal 2027's first quarter, up 27.7 percent. Meiji stock stood at EUR 23.20 on October 5, 2026, its prior close.

Meiji, JP3918000005, Illustration mit AI erstellt.

Meiji Holdings Co. (JP3918000005) saw its fair value estimate rise from JPY 4,485.00 to JPY 4,655.00 on September 25, 2026, according to Simply Wall St. The latest operating figures give that valuation change a stronger earnings backdrop.

Fair value moves to JPY 4,655

The estimate increased by 3.79 percent from JPY 4,485.00, with updated assumptions for revenue growth, profit margins and future price-to-earnings levels, Simply Wall St reported in its September 25, 2026 update.

The target remains above the Tokyo quote, but the valuation signal is not a blanket earnings forecast. It reflects consensus-based assumptions rather than a company commitment.

First-quarter profit accelerates

Meiji reported revenue of JPY 289.4 billion in the first quarter of fiscal 2027, up 27.70 percent from the same period a year earlier, while operating profit reached JPY 22.67 billion, according to Note on September 29, 2026.

Pharmaceutical operating profit increased to JPY 8.40 billion from JPY 4.70 billion in the comparable quarter, a 78.72 percent gain. That segment result helps explain why profit growth is outpacing the group's longer-term revenue profile.

Tokyo quote below yearly high

Meiji's quote on the Tokyo Stock Exchange was last at JPY 4,177.00 on October 7, 2026 at 12:35 p.m. JST. The finance snapshot showed a JPY 2,907.00 to JPY 4,608.00 52-week range, placing the quote JPY 431.00 below the high, or 9.35 percent below that level.

Market capitalization stood at JPY 1.1 trillion on October 7, 2026. The company operates through food and pharmaceutical businesses, according to Reuters.

Meiji stock keeps a valuation gap

The contrast is clear: first-quarter operating profit grew 27.70 percent year over year, while the Tokyo quote remained 9.35 percent below its 52-week high. For investors, the next test is whether pharmaceutical momentum can offset the lower earnings base reported for fiscal 2026.

Meiji's fiscal 2026 revenue was JPY 1.1737 trillion and operating profit was JPY 93.3 billion, with operating profit up 10.20 percent year over year, according to the September 29, 2026 analysis by Note. The full-year fiscal 2027 operating profit guidance is JPY 100.0 billion, as summarized by Simply Wall St.

Tokyo trading sets the reference

At Lang & Schwarz, the prior close was EUR 23.20 for October 5, 2026. The Tokyo Stock Exchange quote was last at JPY 4,177.00 on October 7, 2026 at 12:35 p.m. JST, while the euro reference remained the Lang & Schwarz prior close.

The further course of trading is shown by the continuously updated real-time quote of Meiji stock.